Dr Hivert is an Associate Professor in the Department of Population Medicine at Harvard Medical School. She is a clinical investigator with primary focus on the etiology and primordial prevention of obesity and related co-morbidities, particularly type 2 diabetes and gestational diabetes. Her research expertise include fetal metabolic programming mechanisms and the integration of genetics, epigenetics, and environmental factors contributing to obesity and related disorders. She is the Principal Investigator (PI) of Genetics of Glucose regulation In Gestation and Growth (Gen3G), and co-PI of Project Viva, two independent prospective pre-birth cohorts that investigate the health determinants of mothers and children. She is currently involved in many international consortia investigating the genetics determinants of glycemic regulation during and outside of pregnancy, as well as epigenetics mechanisms linked to prenatal exposures and fetal programming. She is one of the leaders of the international effort “Precision Medicine for Diabetes Initiative” for the field of Gestational Diabetes. At Harvard Medical School, she is the director of the Curricular Theme “Nutrition and Lifestyle Medicine” and the co-director of the Advance Integrated Science Course “Metabolism, Nutrition, and Lifestyle Medicine”.